Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Tofacitinib might be used to treat hair loss.

Ruxolitinib can cause a delayed skin reaction on the nose.

Baricitinib may cause low blood sugar in some patients, so careful monitoring is needed.

Oral cyclosporine combined with Pantogar® effectively treats twenty-nail dystrophy.

The combination treatment showed a higher response rate but no significant survival benefits.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Topical ruxolitinib cream may help treat frontal fibrosing alopecia.

Sintilimab treatment caused hair loss but led to complete tumor remission.

A specific gene variant is linked to severe insulin resistance and hormone imbalance in a teenage girl.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

Ritlecitinib is more effective and cheaper than baricitinib for treating severe alopecia areata.

The combination therapy is safe and more effective for treating pediatric facial and cervical vitiligo.

High-dose intravenous iron therapy doesn't interfere with treatment improvements in IBD patients with iron deficiency anemia.

Ritlecitinib is safe and may effectively treat alopecia areata.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Tribuloside can increase skin pigmentation by enhancing melanin production and distribution.

Rimegepant causes more nausea and skin issues, while ubrogepant causes more muscle issues; personalized treatment is important.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

Cidea is essential for proper lipid storage and secretion in sebaceous glands, affecting skin and hair health.

Bedaquiline, Telmisartan, Diosmin, Azelastine, and Adapalene may be effective treatments for onchocerciasis.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

Adding aripiprazole to the treatment improved hair-pulling symptoms in a teenager.

The framework helps predict adverse effects of blood thinners, improving drug selection for atrial fibrillation.

Two patients treated with TAC for mouth fibrosis improved but developed Cushing's Syndrome symptoms.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Upadacitinib may effectively treat resistant lichen planopilaris.